Novel 3-chloro-6-nitro-1 H-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies
- J Enzyme Inhib Med Chem. 2022 Dec;37(1):151-167. doi: 10.1080/14756366.2021.1995380.
- 1. Laboratoire de Chimie Organique Hétérocyclique, Centre de Recherche des Sciences des Médicaments, Pôle de Compétences Pharmacochimie, URAC 21, Faculté des Sciences, Mohammed V University Rabat, Rabat, Morocco.
- 2. Department of Theoretical and Applied Chemistry, South Ural State University, Chelyabinsk, Russia.
- 3. Department of Medical Applied Chemistry, Chung Shan Medical University, Taichung, Taiwan.
- 4. Department of Medical Education, Chung Shan Medical University Hospital, Taichung, Taiwan.
- 5. G.S. Gill Research Institute, Guru Nanak College, Chennai, India.
- 6. Department of Chemistry, College of Sciences and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- 7. Department of Health and Biological Sciences, Abasyn University, Peshawar, Pakistan.
- 8. Department of Chemistry, Tulane University, New Orleans, LA, USA.
- 9. Department for Chemistry and Biochemistry, Faculty of Agriculture, University of Belgrade, Belgrade, Serbia.
- 10. College of Science, Physics Department, Alfaisal University, Riyadh, Saudi Arabia.
An efficient pathway was disclosed for the synthesis of 3-chloro-6-nitro-1H-indazole derivatives by 1,3-dipolar cycloaddition on dipolarophile compounds 2 and 3. Faced the problem of separation of two regioisomers, a click chemistry method has allowed us to obtain regioisomers of triazole-1,4 with good yields from 82 to 90% were employed. Also, the antileishmanial biological potency of the compounds was achieved using an MTT assay that reported compound 13 as a promising growth inhibitor of Leishmania major. Molecular docking demonstrated highly stable binding with the Leishmania trypanothione reductase enzyme and produced a network of hydrophobic and hydrophilic interactions. Molecular dynamics simulations were performed for TryR-13 complex to understand its structural and intermolecular affinity stability in a biological environment. The studied complex remained in good equilibrium with a structure deviation of ∼1-3 Å. MM/GBSA binding free energies illustrated the high stability of TryR-13 complex. The studied compounds are promising leads for structural optimisation to enhance the antileishmanial activity.
-
Cat. No.Product NameDescriptionTargetResearch Area
-